Last reviewed · How we verify
NCT06217458: CEMinDCIS
The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS
NA trial testing Contrast Enhanced Mammography in DCIS in 100 participants. Not yet recruiting.
31 December 2026
Quick facts
| Lead sponsor | Clinical Hospital Center Rijeka |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 100 |
| Start date | 1 March 2025 |
| Primary completion | 31 December 2026 |
| Estimated completion | 1 January 2027 |
| Sites | 1 location across Croatia |
Drugs / interventions tested
- Contrast Enhanced Mammography
Conditions studied
- DCIS — all drugs for DCIS →
- Breast Carcinoma in Situ — all drugs for Breast Carcinoma in Situ →
- Calcification — all drugs for Calcification →
Sponsor
Clinical Hospital Center Rijeka
Who can join
Adults 18 to 99, female only, with DCIS or Breast Carcinoma in Situ. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study hypothesis is that the rate of inadequate surgical margins after conservative breast surgery for DICS and the rate of reoperation (re-excision or/and mastectomy) is lower in the group of patients who underwent standard preoperative mammography and CEM to assess the extent of DICS, compared to the group of patients for whom the preoperative assessment of the extent of in situ breast cancer was not performed using one of the imaging techniques with contrast medium such as contrast mammography or magnetic resonance imaging.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06217458
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Contrast Enhanced Mammography
Trials testing the same drug.
- NCT05667532 — The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women Wit · NA · recruiting
- NCT04579107 — KARMA Kontrast Evaluating Contrast Enhanced Mammography in Early Detection of Breast Cancer · NA · unknown
- NCT06311695 — Contrast-Enhanced Spectral Mammography (CESM) · Phase 2 · unknown
Other recruiting trials for DCIS
Currently open trials in the same condition.
- NCT05912569 — Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS · NA · recruiting
- NCT04797299 — Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS) · recruiting
- NCT04722692 — Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ · Phase 3 · recruiting
- NCT04084730 — Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer · Phase 2 · recruiting
- NCT04049214 — Perioperative Mindfulness Proposal · NA · recruiting
Other Clinical Hospital Center Rijeka trials
Trials by the same sponsor.
- NCT07446803 — Ultrasound Scoring Methods to Monitor Breathing Problems in Intensive Care Patients · not yet recruiting
- NCT07442708 — Segmental Lung Recruitment: a Randomized Controlled Trial · NA · not yet recruiting
- NCT07098507 — De-escalation in Axillary Surgery for Early-stage Breast Cancer · NA · not yet recruiting
- NCT07123948 — The Correlation Between Red Cell Transfusion and Complications of Prematurity · not yet recruiting
- NCT05697458 — Vascular Calcifications in Kidney Transplant Recipient · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06217458 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clinical Hospital Center Rijeka
- Last refreshed: 6 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06217458.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing